Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2016, Article ID 3621802, 4 pages
http://dx.doi.org/10.1155/2016/3621802
Case Report

A Case of a Gastrointestinal Stromal Tumor Diagnosed at the Postpartum Period

1Dokuz Eylul University School of Medicine, Department of Obstetrics and Gynecology, Izmir, Turkey
2Dokuz Eylul University School of Medicine, Department of Surgery, Izmir, Turkey
3Dokuz Eylul University School of Medicine, Department of Medical Oncology, Izmir, Turkey
4Dokuz Eylul University School of Medicine, Department of Pathology, Izmir, Turkey
5Dokuz Eylul University School of Medicine, Department of Radiodiagnostics, Izmir, Turkey

Received 12 August 2016; Revised 30 October 2016; Accepted 31 October 2016

Academic Editor: Yoshio Yoshida

Copyright © 2016 Sefa Kurt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Introduction. We discuss a rare gastrointestinal stromal tumor (GIST) case detected at the 10th postpartum week and we want to pay attention to the challenges and improvements in the diagnosis, surgery, chemotherapy, and follow-up of this rare tumor accompanied with the review of the current literature. Case Presentation. A 32-year-old multiparous woman presented with abdominal swelling 10 weeks after her second vaginal birth. Abdominal examination revealed a mass starting from the pelvic level and extending to the right upper quadrant. Radiological examinations showed a solid, multiloculated, and hypervascular mass starting from the pelvis and extending to the transverse colon. En bloc mass with a 20 cm jejunal segment resection and a left pelvic side wall peritonectomy with omentectomy was performed. The pathologic examination revealed a high-risk GIST which originated from the jejunum and disseminated to the peritoneum. The patient has been given imatinib 400 mg/day since then. She did not reveal any progression during the 15-month follow-up postoperatively. Conclusion. GIST tumors are rare and there is not sufficient information in the literature regarding its management. In this patient having high risk GIST and GIST sarcomatosis we successfully treated the patient by surgery and adjuvant imatinib chemotherapy.